Sustainability Report

The report describes Daiichi Sankyo Brasil's 2021/2022 performance, including the launch of four medicines and a workforce of 622 employees. It reports 294.6 tCO2e of combined Scope 1 and 2 emissions, while renewable sources supplied 99.6% of energy consumed. Other notable highlights include 131.4 tons of waste generated, 43% of it recycled, and support for 20 projects from eight patient organizations.